Argentina vs Indonesia: Proportion of bloodstream infection due to methicillin-resistant
Argentina
35.7%
in 2023
Indonesia
40.1%
in 2023
Argentina rank
23rd
Indonesia rank
21st
Proportion of bloodstream infection due to methicillin-resistant over time
- Argentina
- Indonesia
How they compare
Indonesia currently reports 40.1% against 35.7% in Argentina, a difference of 4.4%.
That makes Indonesia's figure about 1.1 times Argentina's.
The two have swapped places 2 times across 6 shared years of data; in 2018 it was Indonesia ahead.
Argentina ranks 23rd and Indonesia ranks 21st of 55 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 42.3% | 46.1% | 3.8% | Indonesia |
| 2020s | 35.3% | 37.3% | 2.0% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Argentina or Indonesia?
- Indonesia, at 40.1% against 35.7% in Argentina as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Argentina and Indonesia?
- 4.4%, with Indonesia ahead.
- How many years of comparable data are there for Argentina and Indonesia?
- 6 years are reported by both, from 2018 to 2023.
- How do Argentina and Indonesia rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Argentina ranks 23rd and Indonesia ranks 21st of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.